Proven technology leader to play key role at fast-growing pharmaceutical services firm
|
|||||
PRINCETON, N.J., March 14, 2016 -- APCER Life Sciences, the truly global provider of safety, medical, regulatory, and technology services, announced today that Ms. Aparna Mazumdar has joined the firm as Head of Global Business Solutions. Aparna will lead the development and implementation of technology-based solutions for APCER’s expanding offices and rapidly growing client base.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4061d734-3a14-471e-b850-b6d3287f548f
“We are taking major steps to enhance our information technology and business solutions through significant investments in talent, processes, and assets,” said Suneet Walia, President and CEO of APCER Life Sciences, Inc. “We are pleased to welcome Aparna, a proven technology leader in the pharmaceutical industry, to play a key role in the next phase of our journey.”
Aparna has more than fifteen years’ experience in managing IT organizations and executing enterprise level projects. She worked for twelve years at Sun Pharma in positions of increasing responsibility and was most recently the Global Head of R&D IT at Sun Pharmaceutical Industries Ltd. Prior to that, Aparna worked with Pentasoft Technologies Ltd. as Project Manager & Faculty. She also has three years of research experience.
“APCER has a bold plan to develop products and services that maximize efficiencies and compliance,” said Aparna Mazumdar. “I’m excited to apply the experience I’ve gained inside a dynamic pharmaceutical company to deliver solutions that will provide benefits across the global marketplace.”
Aparna holds a Master of Life Sciences degree from DAVV Indore, a Master of Biotechnology and Engineering from India Institute of Technology Kharagpur, one of India’s most prestigious technical universities, and a Master of Business Administration with specialization in Strategic Management and Information Technology from Management Development Institute, a premier business school in Gurgaon, India.
Aparna will be based in APCER’s Delhi, India office and lead a global team located in Delhi and London, UK.
About APCER Life Sciences
APCER Life Sciences is committed to improving health in partnership with its clients. It brings together safety, medical, regulatory, and technology resources from around the world to ensure that patients receive the safest, most effective therapies possible.
To learn how APCER Life Sciences works together for better health, please follow the company on Twitter, LinkedIn, and Facebook; visit www.apcerls.com; and contact APCER at one of their global offices.
Jill Notte APCER Life Sciences 609-436-4714


Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 



